Ad Code

Responsive Advertisement

Ticker

6/recent/ticker-posts

Psychedelics and non-hallucinogenic analogs work through the same receptor—up to a point

Understanding exactly how psychedelics promote new connections in the brain is critical to developing targeted, non-hallucinogenic therapeutics that can treat neurodegenerative and neuropsychiatric diseases. To achieve this, researchers are mapping the biochemical pathways involved in both neuroplasticity and hallucinations.

from Medical Xpress - latest medical and health news stories https://ift.tt/wtveC3x